Radiofrequency bipolar hemostatic sealer reduces blood loss, transfusion requirements, and cost for patients undergoing multilevel spinal fusion surgery: a case control study

Table 4 Comparison of clinical outcomes in the radiofrequency bipolar hemostatic sealer and control groups

Variable	RBHS group (n = 36)	Control group (n = 38)	Pvalue
Composite outcome (any morbid event)	1 (2.8)	5 (13.1)	0.20
Morbid events^a
Infection	0 (0%)	1 (2.8%)	0.20
Thrombotic	1 (2.8%)	2 (5.3%)	0.87
Renal	1 (2.8%)	2 (5.3%)	0.87
Respiratory	0 (0%)	0 (0%)	NS
Stroke	0 (0%)	0 (0%)	NS
Myocardial infarction	0 (0%)	0 (0%)	NS

NS not significant, RBHS radiofrequency bipolar hemostatic sealer. ^aMorbid events were determined by ICD-9 codes at patient discharge from IMPACT Online (Haemonetics Corp, Braintree, MA, USA).

ISSN: 1749-799X